Interaction of vasoactive intestinal peptide (VIP) with human peripheral blood lymphocytes: specific binding and cyclic AMP production.
VIP binding sites and cyclic AMP production by the peptide have been studied in human blood mononuclear cells before and after selective depletion of or enrichment for T-lymphocytes, B-lymphocytes-K-NK cells and monocytes. The specifically bound 125I-labelled VIP correlated significantly with the presence of B-lymphocytes and/or cells of K-NK system. The stoichiometric data were compatible with the existence of two classes of binding sites. T-lymphocytes and monocytes did not show binding of the tracer. The cyclic AMP production stimulated by VIP correlated significantly with the presence of B-lymphocytes and/or K-NK cells.
D000328:Adult; D001402:B-Lymphocytes / Q000378:metabolism; D001665:Binding Sites; D000242:Cyclic AMP / Q000096:biosynthesis*; D006801:Humans; D066298:In Vitro Techniques; D008214:Lymphocytes / Q000378:metabolism*; D013601:T-Lymphocytes / Q000378:metabolism; D014660:Vasoactive Intestinal Peptide / Q000378:metabolism*
D014660:Vasoactive Intestinal Peptide; D000242:Cyclic AMP